GlaxoSmithKline and Impax Pharmaceuticals terminate their collaboration on IPX066

GlaxoSmithKline (GSK) plc and Impax Pharmaceuticals today announced that they are terminating their collaboration for the development and commercialisation of IPX066 outside the United States and Taiwan.
Source: GSK news - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals